Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.
Détails
Télécharger: 35321933_BIB_2BEA01C77CB1.pdf (906.57 [Ko])
Etat: Public
Version: Author's accepted manuscript
Licence: CC BY-NC 4.0
Etat: Public
Version: Author's accepted manuscript
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_2BEA01C77CB1
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD.
Périodique
European respiratory review
ISSN
1600-0617 (Electronic)
ISSN-L
0905-9180
Statut éditorial
Publié
Date de publication
31/03/2022
Peer-reviewed
Oui
Volume
31
Numéro
163
Pages
210112
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Publication Status: epublish
Résumé
Chronic exposure to environmental pollutants is a major contributor to the development and progression of obstructive airway diseases, including asthma and COPD. Understanding the mechanisms underlying the development of obstructive lung diseases upon exposure to inhaled pollutants will lead to novel insights into the pathogenesis, prevention and treatment of these diseases. The respiratory epithelial lining forms a robust physicochemical barrier protecting the body from inhaled toxic particles and pathogens. Inhalation of airborne particles and gases may impair airway epithelial barrier function and subsequently lead to exaggerated inflammatory responses and airway remodelling, which are key features of asthma and COPD. In addition, air pollutant-induced airway epithelial barrier dysfunction may increase susceptibility to respiratory infections, thereby increasing the risk of exacerbations and thus triggering further inflammation. In this review, we discuss the molecular and immunological mechanisms involved in physical barrier disruption induced by major airborne pollutants and outline their implications in the pathogenesis of asthma and COPD. We further discuss the link between these pollutants and changes in the lung microbiome as a potential factor for aggravating airway diseases. Understanding these mechanisms may lead to identification of novel targets for therapeutic intervention to restore airway epithelial integrity in asthma and COPD.
Mots-clé
Administration, Inhalation, Air Pollutants/adverse effects, Asthma, Humans, Lung, Pulmonary Disease, Chronic Obstructive/drug therapy
Pubmed
Web of science
Création de la notice
09/04/2022 19:12
Dernière modification de la notice
23/11/2022 7:09